Citation Impact
Citing Papers
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
2009
Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function
2012
Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee
2020 Standout
‘”Why me, why now?” Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection
2016
Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future
2004
When aging reaches CD4+ T-cells: phenotypic and functional changes
2013
Leishmaniasis
2018 Standout
Targeting natural killer cells and natural killer T cells in cancer
2012
Role of cytokines and chemokines in idiopathic inflammatory myopathies
2009
KIR matching in hematopoietic stem cell transplantation
2005
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
The CD85j+ NK Cell Subset Potently Controls HIV-1 Replication in Autologous Dendritic Cells
2008 StandoutNobel
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Subcutaneous Immunoglobulin Therapy in the Chronic Management of Myasthenia Gravis: A Retrospective Cohort Study
2016
Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain
2007 Standout
Risk assessment in haematopoietic stem cell transplantation: Histocompatibility
2007
NK cell self tolerance, responsiveness and missing self recognition
2014
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
Macrophages in immunoregulation and therapeutics
2023 Standout
Allostatic load biomarkers of chronic stress and impact on health and cognition
2009 Standout
Pancreatic cancer
2016 Standout
Systemic sclerosis
2017 Standout
Human cytolytic T lymphocytes expressing HLA class-I-specific inhibitory receptors
2005
The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor‐alloreactive T cells causing GVHD
2004
Targeting immunometabolism as an anti-inflammatory strategy
2020
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects
2016
Immunotherapy of myositis: issues, concerns and future prospects
2010
Natural killer cells and other innate lymphoid cells in cancer
2018
Sarcoidosis
2013 Standout
Functions of natural killer cells
2008 Standout
Immunoregulatory Role of NK Cells in Tissue Inflammation and Regeneration
2017
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein
1997 Standout
Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
2013 StandoutNobel
Natural killer cells in liver disease
2012
TCR Specificity Dictates CD94/NKG2A Expression by Human CTL
2002
Subcutaneous immunoglobulin in polymyositis and dermatomyositis: A novel application
2010
Graft-versus-host disease
2009 Standout
Giardiasis – why do the symptoms sometimes never stop?
2010
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
Myasthenia gravis
2019 Standout
Efficacy and patient satisfaction in the use of subcutaneous immunoglobulin immunotherapy for the treatment of auto-immune neuromuscular diseases
2018
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Neo‐ligands for innate immune receptors and the etiology of sterile inflammatory disease
2007 StandoutNobel
Interrelation of inflammation and APP in sIBM: IL-1β induces accumulation of β-amyloid in skeletal muscle
2008
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Neglected Tropical Diseases in Sub-Saharan Africa: Review of Their Prevalence, Distribution, and Disease Burden
2009 Standout
Towards understanding the mode of action of the multifaceted cell adhesion receptor CD146
2009
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
IgG4-related disease
2014 Standout
TREG-cell therapies for autoimmune rheumatic diseases
2014 StandoutNobel
Guidelines for the use of platelet transfusions
2016
Alloreactive killer cells: hindrance and help for haematopoietic transplants
2003
Defining trained immunity and its role in health and disease
2020 Standout
Cell surface glycoproteomic analysis of prostate cancer-derived PC-3 cells
2011 StandoutNobel
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
2015 Standout
MHC class I molecules and kirs in human history, health and survival
2005
NK cells: a lesson from mismatched hematopoietic transplantation
2002
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
IgG Subclasses and Allotypes: From Structure to Effector Functions
2014 Standout
Zoonotic Potential and Molecular Epidemiology ofGiardiaSpecies and Giardiasis
2011 Standout
Formation of the Killer Ig-Like Receptor Repertoire on CD4+CD28null T Cells
2002
Latest Advances in Understanding Preeclampsia
2005 StandoutScience
NK CELL RECOGNITION
2004 Standout
Mechanisms of Cell Protection by Heme Oxygenase-1
2010 Standout
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
2009 Standout
Cold Hemolytic Syndrome
2006
Inflammatory Muscle Diseases
2015 Standout
Different and Divergent Regulation of the KIR2DL4 and KIR3DL1 Promoters
2003
Immune Modulation in Cancer with Antibodies
2013 StandoutNobel
Follicular Helper CD4 T Cells (TFH)
2011 Standout
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self
2006
Impact of β2 integrin deficiency on mouse natural killer cell development and function
2011 StandoutNobel
Primary B Cell Immunodeficiencies: Comparisons and Contrasts
2009
Causes and consequences of higher Leishmania infantum burden in patients with kala‐azar: a study of 625 patients
2017
Real-Time PCR Assay for Detection and Quantification of Leishmania (Viannia) Organisms in Skin and Mucosal Lesions: Exploratory Study of Parasite Load and Clinical Parameters
2013
KIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive Immunity
2002
Chronic Fatigue Syndrome and High Allostatic Load
2006
Dendritic cell maturation by innate lymphocytes
2005 StandoutNobel
Selective Activation of the c-Jun NH2-terminal Protein Kinase Signaling Pathway by Stimulatory KIR in the Absence of KARAP/DAP12 in CD4+ T Cells
2003
IgG4-Related Disease
2013
Clinical Practice Guideline (Update): Adult Sinusitis
2015 Standout
The Relationship between Leishmaniasis and AIDS: the Second 10 Years
2008
Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals
2007 StandoutNobel
Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion
2018 Standout
Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)
2016
Preclinical characterization of 1-7F9, a novel human anti–KIR receptor therapeutic antibody that augments natural killer–mediated killing of tumor cells
2009
Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases
2015
Killer Ig-Like Receptor Haplotype Analysis by Gene Content: Evidence for Genomic Diversity with a Minimum of Six Basic Framework Haplotypes, Each with Multiple Subsets
2002
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
Concept and classification of dystonia.
1988
KIR and disease: a model system or system of models?
2006
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
2020 Standout
Works of N. Schleinitz being referenced
Granulomatous Disease in CVID: Retrospective Analysis of Clinical Characteristics and Treatment Efficacy in a Cohort of 59 Patients
2012
Low Circulating Natural Killer Cell Counts are Associated With Severe Disease in Patients With Common Variable Immunodeficiency
2016
Natural killer cells in human autoimmune diseases
2010
Subcutaneous immunoglobulin administration: an alternative to intravenous infusion as adjuvant treatment for dermatomyositis?
2008
Expression of the β chemokines CCL3, CCL4, CCL5 and their receptors in idiopathic inflammatory myopathies
2004
High dose subcutaneous immunoglobulin for idiopathic inflammatory myopathies and dysimmune peripheral chronic neuropathies treatment: observational study of quality of life and tolerance
2016
Expression of the CD85j (leukocyte Ig‐like receptor 1, Ig‐like transcript 2) receptor for class I major histocompatibility complex molecules in idiopathic inflammatory myopathies
2008
Agglutinines froides, circonstances de découverte chez l’adulte et signification en pratique clinique : analyse rétrospective à propos de 58 patients
2004
Relevance of KIR gene polymorphisms in bone marrow transplantation outcome
2002
Correlation of Clinicoserologic and Pathologic Classifications of Inflammatory Myopathies
2012
Association of Sarcoidosis and Immune Thrombocytopenia
2011
Infections in 252 Patients with Common Variable Immunodeficiency
2008
Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies.
2006
Regulation of Inhibitory and Activating Killer-Cell Ig-Like Receptor Expression Occurs in T Cells After Termination of TCR Rearrangements
2001
Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions
2004
[Diagnostic approach to hypereosinophilia].
1998
Usefulness of 2‐[18F]‐fluoro‐2‐deoxy‐d ‐glucose–Positron Emission Tomography/Computed Tomography for Staging and Evaluation of Treatment Response in IgG4‐Related Disease: A Retrospective Multicenter Study
2013
The temporary use of thrombopoietin‐receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study
2014
REFERENCE VALUES FOR LEISHMANIA INFANTUM PARASITEMIA IN DIFFERENT CLINICAL PRESENTATIONS: QUANTITATIVE POLYMERASE CHAIN REACTION FOR THERAPEUTIC MONITORING AND PATIENT FOLLOW-UP
2006
Pathologies Associated with Serum IgG4 Elevation
2012